
Non-communicable diseases
Affordable, quality treatments for chronic conditions that affect millions of families across the continent.
Afrinova Pharmaceuticals is bringing quality, affordable, locally manufactured medicines closer to the people who need them, starting in Eastern and Southern Africa.
Afrinova Pharmaceuticals Limited is dedicated to bringing high-quality, affordable medicines closer to the people who need them. We focus on treatments for non-communicable diseases and essential injectable medicines, including products that prevent and manage postpartum hemorrhage during childbirth.
Starting in Eastern and Southern Africa, Afrinova aims to expand across the continent, reducing Africa's reliance on imported pharmaceuticals while strengthening access to essential healthcare.


Our product portfolio is built around the treatments that African patients and health systems need most.

Affordable, quality treatments for chronic conditions that affect millions of families across the continent.

Reliable local supply of the injectable medicines that patients, hospitals and clinics depend on every day.

Products that prevent and manage postpartum hemorrhage, helping to reduce maternal death rates in Africa so more mothers come home safely after childbirth.

To become a trusted and competitive African pharmaceutical leader, delivering innovative, locally manufactured medicines while advancing health security and sustainable value creation across the continent.
To manufacture and deliver safe, effective, and affordable medicines through quality-driven production, strategic partnerships, and disciplined investment; expand access to priority treatments; develop local talent and supply chains; and build a resilient pharmaceutical enterprise that creates sustainable value for patients, partners, investors, and communities.
Upholding rigorous standards in every product and process.
Operating transparently, ethically, and responsibly.
Investing in research and applying modern technologies to deliver competitive solutions.
Expanding access to essential medicines without compromising quality.
Building trusted relationships with governments, investors, providers, suppliers, and communities.
Developing African talent and local value chains for responsible, long-term growth.
A clear, disciplined plan to build African pharmaceutical capacity that lasts.
Establish modern, scalable, and quality-compliant pharmaceutical manufacturing facilities in Kenya and Tanzania.
Build a commercially viable product portfolio focused on non-communicable diseases and essential injectable medicines.
Secure regulatory approvals and expand market access across Eastern and Southern Africa, followed by broader continental growth.
Develop financing, technology, distribution, and public-sector partnerships that accelerate scale and reduce execution risk.
Research-led production, medicines health workers can rely on, and care that reaches every generation.




A healthier Africa starts here.
Afrinova offers investors a robust business opportunity with lasting health and economic benefits.

Ask us anything about Afrinova, partnership opportunities or our plans. We reply on WhatsApp and email.
Hello! Have a question about Afrinova or partnering with us? Choose a branch to chat on WhatsApp.